Form 4: Cardinal Health Director Receives RSU Grant

Cardinal Health Director Patricia Hemingway Hall was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Patricia Hemingway Hall, a Director of Cardinal Health Inc. (CAH), was granted 1,067 common shares in the form of restricted share units.
• The transaction occurred on November 5, 2025, with a price of $0 per share, indicating a grant rather than a cash purchase.
• These restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders takes place before that date.
• Following this transaction, Patricia Hemingway Hall beneficially owns 32,264 common shares directly.
• The filing also includes a Limited Power of Attorney, dated May 5, 2025, authorizing specific individuals to file SEC reports on behalf of Patricia Hemingway Hall.

Sentiment

Score: 7

Explanation: The grant of restricted share units to a director is generally a positive signal, indicating alignment of interests and standard compensation practice. It's not a major market-moving event but reflects ongoing corporate governance and compensation structures.

Positives

• The grant of restricted share units to a director aligns the director's interests with long-term shareholder value.

Risks

• The Limited Power of Attorney explicitly states that neither the Company nor any attorney-in-fact assumes liability for the undersigned's responsibility to comply with Exchange Act or Securities Act requirements, any failure to comply, or any obligation for profit disgorgement under Section 16(b) of the Exchange Act.
• The Power of Attorney does not relieve the undersigned from responsibility for compliance with their obligations under the Exchange Act or Securities Act.

Future Outlook

The vesting schedule for the restricted share units indicates a future milestone on November 5, 2026, or earlier if tied to the 2026 Annual Meeting of Shareholders, aligning director incentives with future company performance.

Industry Context

Grants of restricted stock units to directors are a common form of equity compensation in publicly traded companies, particularly within the healthcare distribution and services industry, to align leadership interests with long-term shareholder value and retention.

Comparison to Industry Standards

• Equity compensation for non-employee directors, such as RSU grants, is a standard practice across S&P 500 companies, including peers in the healthcare sector like McKesson Corporation (MCK) and AmerisourceBergen Corporation (ABC), to incentivize long-term performance and retention.
• The vesting schedule tied to a future date or annual meeting is typical for director RSU grants, ensuring continued engagement and alignment with corporate governance cycles.

Corporate Governance

Stakeholder Impact

• **Shareholders**: The grant of restricted share units to a director aligns their interests with long-term shareholder value, as the value of the units is tied to the company's stock performance.
• **Management/Directors**: The RSU grant serves as a component of director compensation, incentivizing continued service and performance.

Next Steps

• The restricted share units are scheduled to vest on November 5, 2026, or potentially earlier if the 2026 Annual Meeting of Shareholders occurs before that date.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director as part of their compensation package. It does not indicate any significant change in the company's fundamentals, strategic direction, or financial health that would warrant a change in investment recommendation. It's a standard insider transaction that aligns director interests with long-term shareholder value but is not a catalyst for a 'buy' or 'sell' decision.

Keywords

Cardinal Health, CAH, Form 4, Insider Transaction, Restricted Share Units, RSU Grant, Director Compensation, Equity Compensation, Beneficial Ownership